Matches in Wikidata for { <http://www.wikidata.org/entity/Q63397692> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q63397692 description "clinical trial" @default.
- Q63397692 description "ensayu clínicu" @default.
- Q63397692 description "klinisch onderzoek" @default.
- Q63397692 description "клінічне випробування" @default.
- Q63397692 name "A Safety, Pharmacokinetic, Pharmacodynamic and Anti-Tumor Study of PF-06873600 as a Single Agent and in Combination With Endocrine Therapy" @default.
- Q63397692 type Item @default.
- Q63397692 label "A Safety, Pharmacokinetic, Pharmacodynamic and Anti-Tumor Study of PF-06873600 as a Single Agent and in Combination With Endocrine Therapy" @default.
- Q63397692 prefLabel "A Safety, Pharmacokinetic, Pharmacodynamic and Anti-Tumor Study of PF-06873600 as a Single Agent and in Combination With Endocrine Therapy" @default.
- Q63397692 P1132 Q63397692-AAC8956E-A6C1-45C6-86DC-6B7A10D8ACFF @default.
- Q63397692 P1476 Q63397692-20D78AE3-B7C5-4C0A-9350-61ABC8D2BDF7 @default.
- Q63397692 P17 Q63397692-EC20B380-7FDF-4D15-AA5D-6F1C762D0588 @default.
- Q63397692 P2899 Q63397692-90A94282-BDF2-4ED6-8A41-F2004FDD38E5 @default.
- Q63397692 P3098 Q63397692-178D10AB-F436-4F57-9280-8AD4260D1493 @default.
- Q63397692 P31 Q63397692-6A6EE9CA-7681-4016-BE44-01725FD99901 @default.
- Q63397692 P580 Q63397692-F21DC814-F8D3-4493-A37F-D8E8D6224168 @default.
- Q63397692 P582 Q63397692-E8D7CE93-C8CC-4670-B597-23C91B568927 @default.
- Q63397692 P6099 Q63397692-352E5E77-7A35-4FB3-9BD5-30ADB5D44985 @default.
- Q63397692 P6153 Q63397692-090603AC-63C1-46E6-B1EF-8816B294F22D @default.
- Q63397692 P6153 Q63397692-213B5325-C241-4B6E-BE9D-8225661CBADE @default.
- Q63397692 P6153 Q63397692-70A6BAB4-B749-402D-9079-AD9DA30F1492 @default.
- Q63397692 P6153 Q63397692-A306208F-7D1D-4D44-AB5B-F9A4D116B1A5 @default.
- Q63397692 P6153 Q63397692-C0647D92-C8B3-4D87-AC48-4A36ABD8B16F @default.
- Q63397692 P6153 Q63397692-F52E30C1-CA1F-46F8-895A-6A79A44C15CF @default.
- Q63397692 P8363 Q63397692-4D0F0B1D-7524-45E2-8A05-AA20F519BD29 @default.
- Q63397692 P859 Q63397692-CBC43BB0-AD02-410E-98EB-40DB972475DE @default.
- Q63397692 P1132 "+220" @default.
- Q63397692 P1476 "PHASE 1/2A DOSE ESCALATION AND EXPANSION STUDY EVALUATING SAFETY, TOLERABILITY, PHARMACOKINETIC, PHARMACODYNAMICS AND ANTI-TUMOR ACTIVITY OF PF-06873600 AS A SINGLE AGENT AND IN COMBINATION WITH ENDOCRINE THERAPY" @default.
- Q63397692 P17 Q30 @default.
- Q63397692 P2899 "+18" @default.
- Q63397692 P3098 "NCT03519178" @default.
- Q63397692 P31 Q30612 @default.
- Q63397692 P580 "2018-03-07T00:00:00Z" @default.
- Q63397692 P582 "2021-12-12T00:00:00Z" @default.
- Q63397692 P6099 Q42824440 @default.
- Q63397692 P6153 Q1061104 @default.
- Q63397692 P6153 Q174710 @default.
- Q63397692 P6153 Q1808012 @default.
- Q63397692 P6153 Q30270369 @default.
- Q63397692 P6153 Q46992910 @default.
- Q63397692 P6153 Q7896459 @default.
- Q63397692 P8363 Q78089383 @default.
- Q63397692 P859 Q206921 @default.